ArticleCancer communications (London, England)2023

A nanotherapeutic strategy to target drug-tolerant cells and overcome EGFR tyrosine kinase inhibitor resistance in lung cancer.

Tatiana Shaurova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.